Glenmark Pharmaceuticals Limited (GLENMARK.BO)

Glenmark Pharma shares drop following major divestment of subsidiary

Shares of Mumbai-based Glenmark Pharmaceuticals fell 4.5% to Rs 790.25 on the National Stock Exchange (NSE) in early trade on Friday, following the company's announcement of a significant divestment in its subsidiary, Glenmark Life Sciences. The decline came after the stock reached a 52-week high of Rs 880 on Thursday.